跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gisfen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gisfen
Approved
STANDARD
Gisfen
Hizon Laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc68ca8f35ae7949
Company
Hizon Laboratories, Inc
Type
Standard
Approval Details
Approval Id
fc68ca8f35ae7949
Drug Approval Philippines Name
Gisfen
Product Name
Gisfen
Registration Number
DRP-7761-02
Brand Name
Gisfen
Generic Name
Mefenamic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Hizon Laboratories, Inc
Trader
GX International, Inc.
Distributor
S.V. More Pharma Corporation
Issuance Date
28 February 2022
Expiry Date
31 May 2026
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc68ca8f35ae7949
Type
Standard
Back to Philippines FDA Approvals